StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report released on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 price objective on shares of Aeterna Zentaris in a research note on Thursday, […]
Research analysts at StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a “buy” rating and issued a $28.00 price target on shares of Aeterna Zentaris in a […]
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $28.00 price target on shares of Aeterna Zentaris in a report on Thursday, August […]
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $28.00 price target on shares of Aeterna Zentaris in a report on Thursday, […]
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 target price on shares of Aeterna Zentaris in a report on Thursday, August […]